(Q44088323)

English

Effect of rosiglitazone on peroxisome proliferator-activated receptor gamma gene expression in human adipose tissue is limited by antiretroviral drug-induced mitochondrial dysfunction

scientific article published in December 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Effect of rosiglitazone on peroxisome proliferator-activated receptor gamma gene expression in human adipose tissue is limited by antiretroviral drug-induced mitochondrial dysfunction (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

(RS)-rosiglitazone

1 reference

based on heuristic

inferred from title

object named as

Sean Emery

9

0 references

author name string

Patrick W G Mallon

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Rebecca Sedwell

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Gary Rogers

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

David Nolan

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Patrick Unemori

5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Jennifer Hoy

6

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Katherine Samaras

7

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Anthony Kelleher

8

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

David A Cooper

10

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Andrew Carr

11

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Rosey Investigators

12

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

language of work or name

0 references

publication date

1 December 2008

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Journal of Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

198

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1794-1803

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1086%2F593179

21 January 2018

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

1 reference

https://api.crossref.org/works/10.1086%2F593179

21 January 2018

Buffalo hump seen in HIV-associated lipodystrophy is associated with hyperinsulinemia but not dyslipidemia

1 reference

https://api.crossref.org/works/10.1086%2F593179

21 January 2018

Combination antiretroviral therapy and the risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1086%2F593179

21 January 2018

Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy

1 reference

https://api.crossref.org/works/10.1086%2F593179

21 January 2018

In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA.

1 reference

https://api.crossref.org/works/10.1086%2F593179

21 January 2018

PPAR-gamma activation mediates adipose depot-specific effects on gene expression and lipoprotein lipase activity: mechanisms for modulation of postprandial lipemia and differential adipose accretion.

1 reference

https://api.crossref.org/works/10.1086%2F593179

21 January 2018

Roles of PPARs in health and disease.

1 reference

https://api.crossref.org/works/10.1086%2F593179

21 January 2018

The role of PPAR-gamma in macrophage differentiation and cholesterol uptake.

1 reference

https://api.crossref.org/works/10.1086%2F593179

21 January 2018

Thiazolidinedione derivative improves fat distribution and multiple risk factors in subjects with visceral fat accumulation--double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1086%2F593179

21 January 2018

No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1086%2F593179

21 January 2018

Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratio

1 reference

https://api.crossref.org/works/10.1086%2F593179

21 January 2018

Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study

1 reference

https://api.crossref.org/works/10.1086%2F593179

21 January 2018

Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis

1 reference

https://api.crossref.org/works/10.1086%2F593179

21 January 2018

PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

1 reference

https://api.crossref.org/works/10.1086%2F593179

21 January 2018

Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator

1 reference

https://api.crossref.org/works/10.1086%2F593179

21 January 2018

The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes

1 reference

https://api.crossref.org/works/10.1086%2F593179

21 January 2018

Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1

1 reference

https://api.crossref.org/works/10.1086%2F593179

21 January 2018

Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy

1 reference

https://api.crossref.org/works/10.1086%2F593179

21 January 2018

Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1086%2F593179

21 January 2018

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

1 reference

https://api.crossref.org/works/10.1086%2F593179

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44088323&oldid=2106469117"